SILEXION THERAPEUTICS CORP Interest Revenue (Expense), Net
SILEXION THERAPEUTICS CORP (SLXN) reported Interest Revenue (Expense), Net of -$14.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:InterestRevenueExpenseNet · last filed 2026-08-14
- SILEXION THERAPEUTICS CORP interest revenue (expense), net for the quarter ending 2026-06-30 was -$14.00K.
- SILEXION THERAPEUTICS CORP interest revenue (expense), net for the quarter ending 2026-03-31 was -$32.00K, a 455.56% decline year-over-year.
- SILEXION THERAPEUTICS CORP interest revenue (expense), net for the quarter ending 2025-12-31 was -$69.00K, a 387.50% decline year-over-year.
- SILEXION THERAPEUTICS CORP interest revenue (expense), net for the quarter ending 2025-09-30 was -$39.00K.
| Period end | Interest Revenue (Expense), Net 3 month | Interest Revenue (Expense), Net 6 month | Interest Revenue (Expense), Net 9 month | Interest Revenue (Expense), Net 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$14.00K 10-Q · filed 2026-08-14 | -$46.00K 10-Q · filed 2026-08-14 | -$115.00K derived: sum of 3 quarters · filed 2026-08-14 | -$154.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | -$32.00K S-1/A · filed 2026-08-10 | -$101.00K derived: sum of 2 quarters · filed 2026-08-10 | -$140.00K derived: sum of 3 quarters · filed 2026-08-10 | -$183.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | -$69.00K derived: S-1/A 12 month − 10-Q 9 month · filed 2026-08-10 | -$108.00K derived: sum of 2 quarters · filed 2026-08-10 | -$151.00K derived: sum of 3 quarters · filed 2026-08-14 | -$142.00K S-1/A · filed 2026-08-10 |
| 2025-09-30 | -$39.00K 10-Q · filed 2025-11-12 | -$82.00K derived: sum of 2 quarters · filed 2026-08-14 | -$73.00K 10-Q · filed 2025-11-12 | -$49.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | -$43.00K 10-Q · filed 2026-08-14 | -$34.00K 10-Q · filed 2026-08-14 | -$10.00K derived: sum of 3 quarters · filed 2026-08-14 | -$10.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | $9.00K S-1/A · filed 2026-08-10 | $33.00K derived: sum of 2 quarters · filed 2026-08-10 | $33.00K derived: sum of 3 quarters · filed 2026-08-10 | $27.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2024-12-31 | $24.00K derived: S-1/A 12 month − 10-Q 9 month · filed 2026-08-10 | $24.00K derived: sum of 2 quarters · filed 2026-08-10 | $18.00K derived: sum of 3 quarters · filed 2026-08-10 | -$1.00K S-1/A · filed 2026-08-10 |
| 2024-09-30 | $0.00 10-Q · filed 2025-11-12 | -$6.00K derived: sum of 2 quarters · filed 2025-11-12 | -$25.00K 10-Q · filed 2025-11-12 | -$58.00K derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | -$6.00K 10-Q · filed 2025-08-12 | -$25.00K 10-Q · filed 2025-08-12 | -$58.00K derived: sum of 3 quarters · filed 2025-08-20 | -$100.00K derived: sum of 4 quarters · filed 2025-08-20 |
| 2024-03-31 | -$19.00K 10-Q · filed 2025-05-13 | -$52.00K derived: sum of 2 quarters · filed 2025-08-20 | -$94.00K derived: sum of 3 quarters · filed 2025-08-20 | -$133.00K derived: sum of 4 quarters · filed 2025-08-20 |
| 2023-12-31 | -$33.00K derived: 8-K 12 month − 10-Q 9 month · filed 2025-08-20 | -$75.00K derived: sum of 2 quarters · filed 2025-08-20 | -$114.00K derived: sum of 3 quarters · filed 2025-08-20 | -$153.00K 8-K · filed 2025-08-20 |
| 2023-09-30 | -$42.00K 10-Q · filed 2024-11-14 | -$81.00K derived: sum of 2 quarters · filed 2024-11-14 | -$120.00K 10-Q · filed 2024-11-14 | |
| 2023-06-30 | -$39.00K 10-Q · filed 2024-08-29 | -$78.00K 10-Q · filed 2024-08-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |